ClinicalTrials.Veeva

Menu

Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound

C

Chulalongkorn University

Status

Unknown

Conditions

Disorder of Skin Donor Site

Treatments

Device: commercial wound dressing
Device: high absorption pad for blood and pus

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

High absorption pad for blood and pus with natural antimicrobial agent or gauze dressing impregnated with paraffin, containing 0.5% chlorhexidine acetate (Bactigras) will be randomly covered on half of split-thickness skin graft donor site wound. The another will be cover on another half of split-thickness skin graft donor site wound. Then, they will be covered with gauzes and bandage. Time to wound healing, amounts of covered dressing gauzes, signs of infection, pain score, erythema index, melanin index, trans epidermal water loss index, and adverse events will be evaluated.

Enrollment

24 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have split-thickness skin graft donor site wound on thigh
  • Age 18-60 years
  • Can read and write
  • Can follow the study protocol
  • Available on appointment date

Exclusion criteria

  • Systemic infection
  • Chronic skin diseases
  • Immune deficiency
  • Allergic to cellulose, chitosan, sericin, and chlorhexidine
  • Psychotic disorders
  • Pregnancy or breast feeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

24 participants in 2 patient groups

high absorption pad for blood and pus
Experimental group
Description:
High absorption pad for blood and pus with natural antimicrobial agent composes of sericin and chitosan. It will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
Treatment:
Device: high absorption pad for blood and pus
commercial wound dressing
Active Comparator group
Description:
Commercial wound dressing is gauze dressing impregnated with paraffin, containing 0.5% chlorhexidine acetate (Bactigras). It will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
Treatment:
Device: commercial wound dressing

Trial contacts and locations

1

Loading...

Central trial contact

Pornanong Aramwit, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems